Literature DB >> 171344

Experimental neuropathy produced by 2,5-hexanedione--a major metabolite of the neurotoxic industrial solvent methyl n-butyl ketone.

P S Spencer, H H Schaumburg.   

Abstract

Chronic exposure of rats to 2,5-hexanedione (CH3COCH2CH2COCH3), a major metabolite of the neurotoxic industrial solvent methyl n-buryl ketone (CH3COCH2CH2CH2CH3), has been shown to cause a clinical peripheral neuropathy with dying-back peripheral and central nervous system degeneration characterized by giant axonal swellings filled with neurofilaments. This pattern of disease is similar to that produced by methyl n-butyl ketone.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 171344      PMCID: PMC492070          DOI: 10.1136/jnnp.38.8.771

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  11 in total

1.  Nervous system degeneration produced by the industrial solvent methyl n-butyl ketone.

Authors:  P S Spencer; H H Schaumburg; R L Raleigh; C J Terhaar
Journal:  Arch Neurol       Date:  1975-04

2.  Glue-sniffing neuropathy.

Authors:  R Korobkin; A K Asbury; A J Sumner; S L Nielsen
Journal:  Arch Neurol       Date:  1975-03

Review 3.  A review of acrylamide neurotoxicity. Part II. Experimental animal neurotoxicity and pathologic mechanisms.

Authors:  P S Spencer; H H Schaumburg
Journal:  Can J Neurol Sci       Date:  1974-08       Impact factor: 2.104

4.  Ultrastructural studies of the dying-back process. I. Peripheral nerve terminal and axon degeneration in systemic acrylamide intoxication.

Authors:  H H Schaumburg; H M Wiśniewski; P S Spencer
Journal:  J Neuropathol Exp Neurol       Date:  1974-04       Impact factor: 3.685

5.  Peripheral neuropathy associated with inhalation of methyl-n-butyl ketone.

Authors:  S Duckett; N Williams; S Francis
Journal:  Experientia       Date:  1974-11-15

6.  Giant axonal neuropathy--a unique case with segmental neurofilamentous masses.

Authors:  A K Asbury; M K Gale; S C Cox; J R Baringer; B O Berg
Journal:  Acta Neuropathol       Date:  1972       Impact factor: 17.088

7.  The pathogenesis of dying-back polyneuropathies. I. An ultrastructural study of experimental tri-ortho-cresyl phosphate intoxication in the cat.

Authors:  J Prineas
Journal:  J Neuropathol Exp Neurol       Date:  1969-10       Impact factor: 3.685

Review 8.  The significance of the "dying back" process in experimental and human neurological disease.

Authors:  J B Cavanagh
Journal:  Int Rev Exp Pathol       Date:  1964

9.  Ultrastructural studies of the dying-back process. II. The sequestration and removal by Schwann cells and oligodendrocytes of organelles from normal and diseases axons.

Authors:  P S Spencer; P K Thomas
Journal:  J Neurocytol       Date:  1974-12

10.  Giant axonal neuropathy. A clinically and morphologically distinct neurological disease.

Authors:  S Carpenter; G Karpati; F Andermann; R Gold
Journal:  Arch Neurol       Date:  1974-11
View more
  35 in total

1.  Toxic polyneuropathy of shoe-industry workers. A study of 122 cases.

Authors:  C Cianchetti; G Abbritti; G Perticoni; A Siracusa; F Curradi
Journal:  J Neurol Neurosurg Psychiatry       Date:  1976-12       Impact factor: 10.154

Review 2.  Solvent neurotoxicity.

Authors:  F D Dick
Journal:  Occup Environ Med       Date:  2006-03       Impact factor: 4.402

3.  An electrophysiological follow up of patients with n-hexane polyneuropathy.

Authors:  Y C Chang
Journal:  Br J Ind Med       Date:  1991-01

4.  Behaviour of urinary 2,5-hexanedione in occupational co-exposure to n-hexane and acetone.

Authors:  A Cardona; D Marhuenda; M J Prieto; J Martí; J F Periago; J M Sánchez
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

5.  2,5-Hexanedione induced apoptosis in cultured mouse DRG neurons.

Authors:  Y Ogawa; H Shimizu; S U Kim
Journal:  Int Arch Occup Environ Health       Date:  1996       Impact factor: 3.015

6.  Relationship between 2,5-hexanedione concentrations in nerve, serum, and urine alone or under co-treatment with different doses of methyl ethyl ketone, acetone, and toluene.

Authors:  W Zhao; J Misumi; T Yasui; K Aoki; T Kimura
Journal:  Neurochem Res       Date:  1998-06       Impact factor: 3.996

7.  Different administration schedules of the same dose of 2,5-hexanedione influence the development of neuropathy and the toxicokinetics.

Authors:  J Misumi; M Nagano; M Futatsuka; W Zhao; M Kudo
Journal:  Neurochem Res       Date:  1997-01       Impact factor: 3.996

8.  Ultrastructure of carbon disulphie neuropathy.

Authors:  I Jirmanová; E Lukás
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

9.  A comparative study on the toxicity of n-hexane and its isomers on the peripheral nerve.

Authors:  Y Ono; Y Takeuchi; N Hisanaga
Journal:  Int Arch Occup Environ Health       Date:  1981       Impact factor: 3.015

10.  A study on biological monitoring of n-hexane exposure.

Authors:  M Iwata; Y Takeuchi; N Hisanaga; Y Ono
Journal:  Int Arch Occup Environ Health       Date:  1983       Impact factor: 3.015

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.